Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies.


Patients with hematological malignancies have high risk for morbidity and mortality from influenza. This study was conducted to evaluate the immunogenicity and reactogenicity of an influenza A(H1N1)pdm09 vaccine among such subjects. Fifty subjects were vaccinated twice during the 2009-2010 season. The antibody response was expressed in terms of mean fold… (More)
DOI: 10.4161/hv.29094


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.